Agenda

Introduction Alan Taylor, PhD

Chronic Hepatitis B Vice President

Pre-clinical Regulatory Affairs
Clinical Pharmacokinetics

Clinical Efficacy & Safety Carol Brosgart, MD

Pivotal studies Vice President

Supportive studies Clinical Research
Further studies

Previous slide

Next slide

Back to first slide

View graphic version